Generic Name: Abana
What is Abana?
It is important that you use the lowest dose that controls your pain and you should not take etoricoxib for longer than necessary. Etoricoxib can also increase your blood pressure, particularly if taken in high doses. This could increase the risk of heart attack or stroke even further. Your doctor should check your blood pressure from time to time, to make sure that it is safe to continue treatment. Etoricoxib is a selective anti-inflammatory, meaning that it blocks the enzyme cyclooxygenase-2 COX-2 responsible for prostaglandin chemicals that play a role in pain and inflammation synthesis without affecting the enzyme COX-1, involved in the production of prostaglandins that protect the lining of the stomach against stomach ulcers.
Stopping this medicine: unless used for long periods of time, this drug can be safely stopped when no longer needed. Prolonged use: etoricoxib should be used for the shortest period possible at the lowest effective dose.
Periodic kidney and liver function test should be performed and patients should contact prescriber if any symptoms related to stomach ulcers appear. Potential risk to the foetus has been reported. This entity has been manually annotated by the ChEBI Team.
It considers submissions in this context. A PBAC decision not to recommend listing or not to recommend changing a listing does not represent a final PBAC view about the merits of the medicine. A company can resubmit to the PBAC or seek independent review of the PBAC decision. While the PBAC rejected the submission in the context of an inferior safety profile in terms of hypertensive related adverse events, compared to celecoxib, other analyses provided to the PBAC in the submission demonstrates that in patients with OA, the effect of etoricoxib 30mg and 60mg on blood pressure is generally similar to that of non-selective NSAIDs such as the most commonly used NSAID in Australia, diclofenac.
Following its review of NSAIDs in 2006, the TGA now requires the Product Information documents of all registered prescription-selective NSAIDs reviewed to contain statements to the effect that "NSAIDs may lead to the onset of new hypertension or worsening of pre-existing hypertension…. Purpose of Application The submission requested a restricted benefit listing for the symptomatic treatment of osteoarthritis.
Background A listing for the symptomatic treatment of osteoarthritis was first requested at the March 2004 meeting. Registration Status Etoricoxib 60 mg, 90 mg and 120 mg tablets were TGA registered on 30 September 2002 and 30 mg tablets on 11 April 2008 for the following indications: Symptomatic treatment of the signs and symptoms of osteoarthritis OA Treatment of acute gouty arthritis Treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures.
Economic Analysis The submission presented a cost minimisation analysis. Context for Decision The PBAC helps decide whether and, if so, how medicines should be subsidised in Australia. Cardiovascular outcomes with etoricoxib and diclofenac in patients with OA and RA arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term MEDAL programme: a randomised comparison.
How should I take Abana?
It is important that you use the lowest dose that controls your pain and you should not take etoricoxib for longer than necessary. Etoricoxib can also increase your blood pressure, particularly if taken in high doses. This could increase the risk of heart attack or stroke even further. Your doctor should check your blood pressure from time to time, to make sure that it is safe to continue treatment.
Etoricoxib is a selective anti-inflammatory, meaning that it blocks the enzyme cyclooxygenase-2 COX-2 responsible for prostaglandin chemicals that play a role in pain and inflammation synthesis without affecting the enzyme COX-1, involved in the production of prostaglandins that protect the lining of the stomach against stomach ulcers.
What should I avoid while taking Abana?
The EDGE study included 7,111 OA patients treated with a dose of etoricoxib 90 mg daily 1. The EDGE II study included 4,086 RA patients treated with etoricoxib 90 mg daily or diclofenac 150 mg daily for a mean period of 19. Use of gastroprotective agents and low dose aspirin were permitted in the studies. Overall Safety: There was no significant difference between etoricoxib and diclofenac in the rate of cardiovascular thrombotic events.
Cardiorenal adverse events were observed more frequently with etoricoxib than with diclofenac, and this effect was dose-dependent see specific results below. Gastrointestinal and hepatic adverse events were observed significantly more frequently with diclofenac than etoricoxib.
Abana side effects
Common with other COX-2 selective NSAIDS, etoricoxib is associated with less gastro-intestinal adverse effects than non-selective NSAIDS, but the relative risks of cardiovascular events in such patients are unclear.
There is no evidence that etoricoxib has advantages or disadvantages compared with other COX-2 selective NSAIDS. Arthritis is the inflammation of a joint. Osteoarthritis is caused by inflammation, breakdown, and eventual loss of cartilage in the joints.
Rheumatoid arthritis causes chronic inflammation of the joints, the tissue around the joints, as well as other organs in the body.
Common Abana ide effects may include:
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions.
It is used in the treatment of various types of inflammation, pain and fever.
One group received the COX-2 inhibitor etoricoxib, while the other group received tramadol, an opioid narcotic-like drug similar to codeine.
Rheumatoid arthritis The recommended dose is 90 mg once daily.
No, etoricoxib is not an over the counter OTC product. It is a prescription medicineContent on this page was last updated on 09 June, 2017, by Dr. Varun Gupta MD Pharmacology Popular Medicine ManufacturersCipla LtdSun Pharmaceutical Industries LtdElan Pharma India Pvt LtdMankind Pharma LtdLupin LtdReckitt Benckiser3M India LimitedMedicine By SaltsCetirizineLevocetirizine AmlodipineRanitidineParacetamolMetforminNorethisteronePopular Prescription MedicinesRantac TabletsZerodol-SP TabletsCyclopam TabletsSpasmo Proxyvon Plus CapsuleNormaxin TabletsMontek Lc TabletsDolo TabletsOther LinksTrendsBusiness PartnershipsAbout usNeed Help.
Where can I get more information?
This medicine should be used with caution if you have diarrhea or any other condition causing extreme dehydration.
There is no evidence that etoricoxib has advantages or disadvantages compared with other COX-2 selective NSAIDS.